The Global Companion Diagnostics Market was valued at USD 2.03 billion in 2016 and is projected to reach USD 10.30 billion by 2025, growing at a CAGR of 19.78% from 2017 to 2025.
A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product.
To Get Sample Report @ https://www.ozonemarketreports.com/sample-request/global-companion-diagnostics-market/25812
Market Dynamics:
1. Market Drivers
1.1 Improvements in Regulatory Guidelines
1.2 Increase in the number of cancer patients all over the globe
1.3 Growing demands of targeted therapies
1.4 Increasing collaborations to promote companion diagnosis technology
2. Market Restraints
2.1 Reimbursement issues depending on regional economy
Market Segmentation:
1. Global Companion Diagnostics Market, by End User:
1.1 Pharma and Biotech Companies
1.2 Reference Laboratories
1.3 Others
2. Global Companion Diagnostics Market, by Indication:
2.1 Oncology
2.1.1 Breast Cancer
2.1.2 Lung Cancer
2.1.3 Colorectal Cancer
2.1.4 Melanoma
To Read complete Report @ https://www.ozonemarketreports.com/pharmaceuticals-and-healthcare/global-companion-diagnostics-market-/25812
2.1.5 Gastric Cancer
2.1.6 Other Cancers Toiletries
2.2 Neurology
2.3 Infectious diseases
2.4 Other indications
3. Global Companion Diagnostics Market, by Products and Services:
3.1 Assay Kits and Reagents
3.2 Software & Services
4. Global Companion Diagnostics Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. F. Hoffmann-La Roche AG
2. Agilent Technologies, Inc.
3. Qiagen N.V.
4. Thermo Fisher Scientific Inc.
5. Abbott Laboratories, Inc.
6. Biomérieux SA
7. Danaher Corporation
8. Illumina, Inc.
9. Myriad Genetics, Inc.
10. Arup Laboratories Inc.
11. Sysmex Corporation
12. Hologic Inc.
13. Novartis AG
14. Almac Group
15. Abnova Corporation
To Browse Similar Report @ https://www.ozonemarketreports.com/category/pharmaceuticals-and-healthcare/11
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.